Review of Garcinia mangostana and its Xanthones in Metabolic Syndrome and Related Complications

Phytotherapy Research

Volumn 31, Issue 8, 2017, Pages 1173-1182

  Tousian Shandiz, Hourieh ^a   Razavi, Bibi Marjan ^b   Hosseinzadeh, Hossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

anti obesity; Garcinia mangostana; mangosteen; metabolic syndrome; obesity; Mangostin

Indexed keywords

ALPHA MANGOSTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE; MANGOSTIN; PLANT EXTRACT;

ABDOMINAL OBESITY; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOBESITY ACTIVITY; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DRUG ACTIVITY; DYSLIPIDEMIA; GARCINIA MANGOSTANA; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIFESPAN; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; REVIEW; ANIMAL; CHEMISTRY;

ANIMALS; GARCINIA MANGOSTANA; HUMANS; METABOLIC SYNDROME X; OBESITY; PLANT EXTRACTS; XANTHONES;

EID: 85021455037     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5862     Document Type: Review

References (91)

1. Abdallah HM, El-Bassossy H, Mohamed GA, et al. 2016a. Phenolics from Garcinia mangostana inhibit advanced glycation endproducts formation: effect on amadori products, cross-linked structures and protein thiols. Molecules 21: 251.
2. Abdallah HM, El-Bassossy HM, Mohamed GA, et al. 2016b. Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation. BMC Complement Altern Med 16: 359.
3. Akaberi M, Hosseinzadeh H. 2016. Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome. Phytother Res 30: 540–556.
4. Amaral S, Moreno AJ, Santos MS, et al. 2006. Effects of hyperglycemia on sperm and testicular cells of Goto-Kakizaki and streptozotocin-treated rat models for diabetes. Theriogenology 66: 2056–2067.
5. An J, Kim D, Lee T, et al. 2016. Effect of Rubus occidentalis extract on metabolic parameters in subjects with prediabetes: a proof-of-concept, randomized, double-blind, placebo-controlled clinical trial. Phytother Res 30: 1634–1640.
6. Asasutjarit R, Larpmahawong P, Fuongfuchat A, et al. 2014. Physicochemical properties and anti-Propionibacterium acnes activity of film-forming solutions containing alpha-mangostin-rich extract. AAPS Pharm Sci Tech 15: 306–316.
7. Bonomini F, Rodella LF, Rezzani R. 2015. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis 6: 109–120.
8. Buelna-Chontal M, Correa F, Hernandez-Resendiz S, et al. 2011. Protective effect of alpha-mangostin on cardiac reperfusion damage by attenuation of oxidative stress. J Med Food 14: 1370–1374.
9. Bumrungpert A, Kalpravidh RW, Chitchumroonchokchai C, et al. 2009. Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J Nutr 139: 1185–1191.
10. Bumrungpert A, Kalpravidh RW, Chuang CC, et al. 2010. Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. J Nutr 140: 842–847.
11. Cade WT. 2008. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 88: 1322–1335.
12. Chae HS, Kim EY, Han L, et al. 2016a. Xanthones with pancreatic lipase inhibitory activity from the pericarps of Garcinia mangostana L. (Guttiferae). Eur J Lipid Sci Technol 118: 1416–1421.
13. Chae HS, Kim YM, Bae JK, et al. 2016b. Mangosteen extract attenuates the metabolic disorders of high-fat-fed mice by activating AMPK. J Med Food 19: 148–154.
14. Chen LG, Yang LL, Wang CC. 2008. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol 46: 688–693.
15. Chin YW, Jung HA, Chai H, et al. 2008. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen). Phytochemistry 69: 754–758.
16. Chin YW, Shin E, Hwang BY, et al. 2011. Antifibrotic constituents from Garcinia mangostana. Nat Prod Commun 6: 1267–1268.
17. Chitchumroonchokchai C, Riedl KM, Suksumrarn S, et al. 2012. Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J Nutr 142: 675–680.
18. Cho BO, Ryu HW, So Y, et al. 2014. Anti-inflammatory effect of mangostenone F in lipopolysaccharide-stimulated RAW264.7 macrophages by suppressing NF-kappaB and MAPK activation. Biomol Ther (Seoul) 22: 288–294.
19. Choi YH, Bae JK, Chae HS, et al. 2015. alpha-Mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPARgamma pathways in high-fat diet-induced obese mice. J Agric Food Chem 63: 8399–8406.
20. Cristancho AG, Lazar MA. 2011. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722–734.
21. Devi Sampath P, Vijayaraghavan K. 2007. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 21: 336–339.
22. Doi H, Shibata MA, Shibata E, et al. 2009. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res 29: 2485–2495.
23. Duvnjak L, Duvnjak M. 2009. The metabolic syndrome—an ongoing story. J Physiol Pharmacol 60: 19–24.
24. Fatmawati S, Ersam T, Shimizu K. 2015. The inhibitory activity of aldose reductase in vitro by constituents of Garcinia mangostana Linn. Phytomedicine 22: 49–51.
25. Gaunay G, Nagler HM, Stember DS. 2013. Reproductive sequelae of diabetes in male patients. Endocrinol Metab Clin North Am 42: 899–914.
26. Gotto AM. 2002. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J 144: S33–S42.
27. Grundy SM, Cleeman JI, Daniels SR, et al. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752.
28. Gulati O. 2015. Pycnogenol® in metabolic syndrome and related disorders. Phytother Res 29: 949–968.
29. Haruenkit R, Poovarodom S, Leontowicz H, et al. 2007. Comparative study of health properties and nutritional value of durian, mangosteen, and snake fruit: experiments in vitro and in vivo. J Agric Food Chem 55: 5842–5849.
30. Hassani FV, Shirani K, Hosseinzadeh H. 2016. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review. Naunyn Schmiedebergs Arch Pharmacol 389: 931–949.
31. Hosseini A, Hosseinzadeh H. 2015. A review on the effects of Allium sativum (Garlic) in metabolic syndrome. J Endocrinol Invest 38: 1147–1157.
32. Hosseinzadeh H, Nassiri-Asl M. 2014. Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J Endocrinol Invest 37: 783–788.
33. Huang TH, Kota BP, Razmovski V, et al. 2005. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol 96: 3–14.
34. Huang HJ, Chen WL, Hsieh RH, et al. 2014. Multifunctional effects of mangosteen pericarp on cognition in C57BL/6J and triple transgenic Alzheimer's mice. Evid Based Complement Alternat Med 2014: 813672.
35. Ibrahim MY, Hashim NM, Mariod AA, et al. 2016. α-Mangostin from Garcinia mangostana Linn: an updated review of its pharmacological properties. Arabian J Chem 9: 317–329.
36. Iyengar N M, Hudis C A, Dannenberg A J. 2013. Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ Book: 46–51.
37. Jang HY, Kwon OK, Oh SR, et al. 2012. Mangosteen xanthones mitigate ovalbumin-induced airway inflammation in a mouse model of asthma. Food Chem Toxicol 50: 4042–4050.
38. Janhom P, Dharmasaroja P. 2015. Neuroprotective effects of alpha-mangostin on MPP(+)-induced apoptotic cell death in neuroblastoma SH-SY5Y cells. J Toxicol 2015: 919058.
39. Jariyapongskul A, Areebambud C, Suksamrarn S, et al. 2015. Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. Biomed Res Int 2015: 785826.
40. Jiang HZ, Quan XF, Tian WX, et al. 2010. Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana. Bioorg Med Chem Lett 20: 6045–6047.
41. Jung HA, Su BN, Keller WJ, et al. 2006. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem 54: 2077–2082.
42. Karagozian R, Derdak Z, Baffy G. 2014. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism 63: 607–617.
43. Langin D. 2006. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53: 482–491.
44. Leong XF, Rais Mustafa M, Jaarin K. 2013. Nigella sativa and its protective role in oxidative stress and hypertension. Evid Based Complement Alternat Med 2013: 120732.
45. Leontowicz M, Leontowicz H, Drzewiecki J, et al. 2007. Two exotic fruits positively affect rat's plasma composition. Food Chem 102: 192–200.
46. Li G, Petiwala SM, Nonn L, et al. 2014. Inhibition of CHOP accentuates the apoptotic effect of alpha-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells. Biochem Biophys Res Commun 453: 75–80.
47. Liu QY, Wang YT, Lin LG. 2015a. New insights into the anti-obesity activity of xanthones from Garcinia mangostana. Food Funct 6: 383–393.
48. Liu Y, Park JM, Chang KH, et al. 2015b. alpha- and gamma-Mangostin cause shape changes, inhibit aggregation and induce cytolysis of rat platelets. Chem Biol Interact 240: 240–248.
49. Liu Q, Li D, Wang A, et al. 2016. Nitric oxide inhibitory xanthones from the pericarps of Garcinia mangostana. Phytochemistry 131: 115–123.
50. Loo AE, Huang D. 2007. Assay-guided fractionation study of alpha-amylase inhibitors from Garcinia mangostana pericarp. J Agric Food Chem 55: 9805–9810.
51. Ming-Hui WANG, Zhang KJ, Qin-Lan GU, et al. 2017. Pharmacology of mangostins and their derivatives: a comprehensive review. Chin J Nat Med 15: 81–93.
52. Miranda PJ, DeFronzo RA, Califf RM, et al. 2005. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149: 33–45.
53. Mollazadeh H, Hosseinzadeh H. 2016. Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iran J Basic Med Sci 19: 1258–1270.
54. Nava Catorce M, Acero G, Pedraza-Chaverri J, et al. 2016. Alpha-mangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J mice. J Neuroimmunol 297: 20–27.
55. Nelli GB, K AS, Kilari EK. 2013. Antidiabetic effect of alpha-mangostin and its protective role in sexual dysfunction of streptozotocin induced diabetic male rats. Syst Biol Reprod Med 59: 319–328.
56. Obolskiy D, Pischel I, Siriwatanametanon N, et al. 2009. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res 23: 1047–1065.
57. Padmanabhan M, Arumugam G. 2014. Effect of Persea americana (avocado) fruit extract on the level of expression of adiponectin and PPAR-gamma in rats subjected to experimental hyperlipidemia and obesity. J Complement Integr Med 11: 107–119.
58. Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, et al. 2008. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol 46: 3227–3239.
59. Phyu MP, Tangpong J. 2014. Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment. Food Chem Toxicol 70: 151–156.
60. Pothitirat W, Chomnawang MT, Gritsanapan W. 2010. Anti-acne-inducing bacterial activity of mangosteen fruit rind extracts. Med Princ Pract 19: 281–286.
61. Quan X, Wang Y, Ma X, et al. 2012. alpha-Mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase. PLoS One 7: e33376.
62. Razavi BM, Hosseinzadeh H. 2014. A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J Endocrinol Invest 37: 1031–1040.
63. Razavi BM, Hosseinzadeh H. 2016. Saffron: a promising natural medicine in the treatment of metabolic syndrome. J Sci Food Agric 97: 1679–1685.
64. Ryu HW, Cho JK, Curtis-Long MJ, et al. 2011. alpha-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry 72: 2148–2154.
65. Sahebkar A. 2013. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors 39: 197–208.
66. Sampath PD, Vijayaragavan K. 2008. Ameliorative prospective of alpha-mangostin, a xanthone derivative from Garcinia mangostana against beta-adrenergic cathecolamine-induced myocardial toxicity and anomalous cardiac TNF-alpha and COX-2 expressions in rats. Exp Toxicol Pathol 60: 357–364.
67. Satoh M, Ishikawa Y, Takahashi Y, et al. 2008. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198: 347–353.
68. Sil R, Chakraborti A. 2016. Oxidative inactivation of liver mitochondria in high fructose diet-induced metabolic syndrome in rats: effect of glycyrrhizin treatment. Phytother Res 30: 1503–1512.
69. Singh S, Malini T, Rengarajan S, et al. 2009. Impact of experimental diabetes and insulin replacement on epididymal secretory products and sperm maturation in albino rats. J Cell Biochem 108: 1094–1101.
70. Stolar M. 2010. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 123: S3–11.
71. Suksamrarn S, Komutiban O, Ratananukul P, et al. 2006. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharm Bull(Tokyo) 54: 301–305.
72. Syam S, Bustamam A, Abdullah R, et al. 2014. beta Mangostin suppress LPS-induced inflammatory response in RAW 264.7 macrophages in vitro and carrageenan-induced peritonitis in vivo. J Ethnopharmacol 153: 435–445.
73. Taher M, Mohamed Amiroudine MZ, Tengku Zakaria TM, et al. 2015. alpha-Mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPARgamma, GLUT4, and leptin expressions. Evid Based Complement Alternat Med 2015: 740238.
74. Taher M, Tg Zakaria TM, Susanti D, et al. 2016. Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats. BMC Complement Altern Med 16: 135.
75. Tanaka K, Nagata D, Hirata Y, et al. 2011. Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice. Atherosclerosis 215: 366–373.
76. Tangpong J, Miriyala S, Noel T, et al. 2011. Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuroscience 175: 292–299.
77. Tep-Areenan P, Suksamrarn S. 2012. Mechanisms of vasorelaxation to gamma-mangostin in the rat aorta. J Med Assoc Thai 95: S63–S68.
78. Tewtrakul S, Wattanapiromsakul C, Mahabusarakam W. 2009. Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells. J Ethnopharmacol 121: 379–382.
79. Trayhurn P, Wood IS. 2005. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33: 1078–1081.
80. Tzanetakou IP, Katsilambros NL, Benetos A, et al. 2012. “Is obesity linked to aging?”: adipose tissue and the role of telomeres. Ageing Res Rev 11: 220–229.
81. Udani JK, Singh BB, Barrett ML, et al. 2009. Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study. Nutr J 8: 48.
82. Walker EB. 2007. HPLC analysis of selected xanthones in mangosteen fruit. J Sep Sci 30: 1229–1234.
83. Wang JJ, Sanderson BJ, Zhang W. 2012. Significant anti-invasive activities of alpha-mangostin from the mangosteen pericarp on two human skin cancer cell lines. Anticancer Res 32: 3805–3816.
84. Wang A, Liu Q, Ye Y, et al. 2015. Identification of hepatoprotective xanthones from the pericarps of Garcinia mangostana, guided with tert-butyl hydroperoxide induced oxidative injury in HL-7702 cells. Food Funct 6: 3013–3021.
85. Wang SN, Li Q, Jing MH, et al. 2016. Natural xanthones from Garcinia mangostana with multifunctional activities for the therapy of Alzheimer's disease. Neurochem Res 41: 1806–1817.
86. Watanapokasin R, Jarinthanan F, Jerusalmi A, et al. 2010. Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: caspase-dependent apoptosis induction in vitro and in mice. Appl Biochem Biotechnol 162: 1080–1094.
87. Weecharangsan W, Opanasopit P, Sukma M, et al. 2006. Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.). Med Princ Pract 15: 281–287.
88. Wihastuti TA, Sargowo D, Tjokroprawiro A, et al. 2014. Vasa vasorum anti-angiogenesis through H(2)O(2), HIF-1alpha, NF-kappaB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn.) in hypercholesterol-diet-given Rattus norvegicus Wistar strain. Vasc Health Risk Manag 10: 523–531.
89. Wihastuti TA, Widodo MA, Heriansyah T, et al. 2015. Study of the inhibition effect of ethanolic extract of mangosteen pericarp on atherogenesis in hypercholesterolemic rat. Asian Pac J Trop Disease 5: 830–834.
90. Xie Z, Sintara M, Chang T, et al. 2015. Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trial. Food Sci Nutr 3: 342–348.
91. Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A. 2016. Flaxseed supplementation in metabolic syndrome management: a pilot randomized, open-labeled, controlled study. Phytother Res 30: 1339–1344.